New Indications and Dosage Forms for 2007

January 9, 2007

• FDA Approves MedImmune's Refrigerated Formulation of FluMist

January 30, 2007

• Pharmion Corporation Announces FDA Approval of Vidaza NDASupplement for IV Administration

January 31, 2007

• FDA Approves NovoLog Category Change for Use in Pregnant Women withType 1 Diabetes

February 26, 2007

• FDA Approves Cymbalta for Treatment of Generalized Anxiety Disorder

February 27, 2007

• Humira (Adalimumab) Receives FDA Approval For Treatment of Crohn'sDisease

March 2, 2007

• FDA Approves Astellas' Vaprisol for the Treatment of Hypervolemic Hyponatremia

April 2, 2007

• FDA Approves Rhophylac for the Treatment of Immune ThrombocytopenicPurpura (ITP)

April 13, 2007

• FDA Approves New Dose of Risperdal Consta for SchizophreniaTreatment

April 30, 2007

• Duramed's Enjuvia (Synthetic Conjugated Estrogens, B) TabletsReceives Two New FDA Approvals

May 24, 2007

• FDA Approves Tindamax for Bacterial Vaginosis

June 1, 2007

• FDA Approves Norditropin for Treatment of Short Stature Associatedwith a Rare Genetic Disorder

June 15, 2007

• FDA Approves New Route of Administration for Rapid-Acting Apidra Providing an Additional Treatment Option for Hospitalized Diabetes Patients with High Blood Sugar Levels

June 22, 2007

• FDA Approves First Drug for Treating Fibromyalgia - Lyrica

July 9, 2007

• Exelon Patch, the First and Only Skin Patch for the Treatment of Alzheimer's Disease, Receives First Worldwide Approval in US

August 6, 2007

• Indevus Announces FDA Approval of Sanctura XR

August 14, 2007

• CV Therapeutics Launches 1000 mg Ranexa Tablet

August 20, 2007

• Reclast Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis

August 22, 2007

• FDA Approves Risperdal to Treat Adolescents with Schizophrenia andChildren and Adolescents with Bipolar Mania

September 4, 2007

• MGI Pharma and Helsinn Announce Aloxi sNDA Approval Allowing forRepeated Dosing for Cancer Patients Receiving Multiple DayChemotherapy Regimens

September 19, 2007

• FDA Approves Expanded Label for FluMist to Include Children Two to Five Years of Age

September 21, 2007

• Norditropin Approved for Treatment of Children with Short StatureAssociated with Turner Syndrome

October 1, 2007

• FDA Approves Symlin Pen-Injector Devices Offering Convenience andAccuracy for Symlin Use
• Taxotere (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery

October 15, 2007

• FDA Expands Velcade (Bortezomib) for Injection Label for Patientswith Multiple Myeloma

November 6, 2007

• U.S. Food and Drug Administration Approves Abilify (aripiprazole) for Adolescent Patients With Schizophrenia

November 9, 2007

• Crestor Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol

November 16, 2007

• Seroquel XR Receives Approval From FDA for Maintenance Treatment ofSchizophrenia

November 19, 2007

• FDA Approves Nexavar (sorafenib) for Unresectable Hepatocellular Carcinoma

November 20, 2007

• U.S. Food and Drug Administration Approves Abilify (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)

November 30, 2007

• FDA Approves Cymbalta for Maintenance Treatment of Major Depressive Disorder

December 3, 2007

• FDA Approves Diovan for Treatment of High Blood Pressure in Children

December 19, 2007

• FDA Approves New Mechanism of Action Labeling for Ranexa